IMPLICATION OF L-TYPE CA2+ CHANNELS IN NONCHOLINERGIC ADRENAL CATECHOLAMINE SECRETION BY ENDOTHELIN-1 IN-VIVO

被引:14
作者
YAMAGUCHI, N
机构
关键词
CHROMAFFIN CELLS; DIHYDROPYRIDINE; CALCIUM CHANNELS; NICOTINIC RECEPTORS; MUSCARINIC RECEPTORS; ADRENOMEDULLA;
D O I
10.1152/ajpregu.1995.269.2.R287
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the present study was to investigate if either dihydropyridine-sensitive L-type Ca2+ channels or cholinergic receptor-mediated mechanisms are implicated in endothelin-1 (ET)-induced adrenal catecholamine (CA) secretion in anesthetized dogs. ET was locally administered to the left adrenal gland via the left adrenolumbar artery. Plasma CA concentrations in adrenal venous and aortic blood were determined by a highperformance liquid chromatography method. In the control group, local infusion (1 min, 0.5 ml/min) of ET (the fixed total dose of 0.5 mu g given to the gland or similar to 0.0197 mu g/kg of body weight) resulted in a sharp increase in the basal CA output, followed by a rapid decline, and a relatively slow secondary response lasted over a period of 15-30 min. In the second group treated with nifedipine (5 mu g or similar to 0.207 mu g/kg) similarly administered 10 min before ET infusion, the ET-induced first steep increase in CA output was significantly attenuated by similar to 75% (P < 0.05, n = 6). In dogs similarly receiving either pentolinium (1 mg or similar to 0.041 mg/kg) or atropine (0.5 mg or similar to 0.018 mg/kg), the ET-induced CA response remained unchanged. The results indicate that ET-induced adrenal CA release was largely mediated by the activation of dihydropyridine-sensitive L-type Ca2+ channels. Furthermore, neither nicotinic nor muscarinic receptors were functionally implicated in the CA response to ET. The study suggests the existence of noncholinergic mechanisms involved in the secretory action of ET on the adrenal medulla in the dog in vivo.
引用
收藏
页码:R287 / R293
页数:7
相关论文
共 28 条
[11]   ENDOTHELIN - A REVIEW OF ITS EFFECTS AND POSSIBLE MECHANISMS OF ACTION [J].
LOVENBERG, W ;
MILLER, RC .
NEUROCHEMICAL RESEARCH, 1990, 15 (04) :407-417
[13]  
MASAKI T, 1990, ADV SEC MESS PHOSPH, V24, P425
[14]   ENDOTHELINS - FROM RECEPTORS TO MEDICINE [J].
MILLER, RC ;
PELTON, JT ;
HUGGINS, JP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (02) :54-60
[15]   VOLTAGE-INDEPENDENT CATECHOLAMINE RELEASE MEDIATED BY THE ACTIVATION OF MUSCARINIC RECEPTORS IN GUINEA-PIG ADRENAL-GLANDS [J].
NAKAZATO, Y ;
OHGA, A ;
OLESHANSKY, M ;
TOMITA, U ;
YAMADA, Y .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (01) :101-109
[16]   DYNAMICS OF THE SECRETORY RESPONSE EVOKED BY ENDOTHELIN-1 IN ADRENAL CHROMAFFIN CELLS [J].
OHARAIMAIZUMI, M ;
KUMAKURA, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 :S156-S158
[17]   ENDOTHELINS - MULTIFUNCTIONAL RENAL PEPTIDES [J].
SIMONSON, MS .
PHYSIOLOGICAL REVIEWS, 1993, 73 (02) :375-411
[18]   NEUROENDOCRINE ACTIONS OF ENDOTHELINS [J].
STOJILKOVIC, SS ;
CATT, KJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (10) :385-391
[19]   ENDOTHELIN INHIBITS PRESYNAPTIC ADRENERGIC NEUROTRANSMISSION IN RAT MESENTERIC-ARTERY [J].
TABUCHI, Y ;
NAKAMARU, M ;
RAKUGI, H ;
NAGANO, M ;
MIKAMI, H ;
OGIHARA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :803-808
[20]   ENHANCEMENT BY ENDOTHELIN-1 OF THE RELEASE OF CATECHOLAMINES FROM THE CANINE ADRENAL-GLAND IN RESPONSE TO SPLANCHNIC NERVE-STIMULATION [J].
TAKEUCHI, A ;
KIMURA, T ;
SATOH, S .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, 19 (09) :663-666